Report - SSG XVIII XVIII_February2008.pdf · 2008-11-04 · SSG XVIII Short (12 months) versus long (36 months) du-ration of adjuvant treatment with the tyrosine kinase inhibitor imatinib

Please pass captcha verification before submit form